Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04319809 · ClinicalTrials.gov registry record · NA

Object Finder for a Retinal Prosthesis

A NA study of Retinitis Pigmentosa, sponsored by Minnesota HealthSolutions.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT04319809 is a NA study of Retinitis Pigmentosa that has completed, run by Minnesota HealthSolutions. The registered enrollment target is 9 participants, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04319809, a NA study of Retinitis Pigmentosa, has completed, sponsored by Minnesota HealthSolutions.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The proposed project seeks to provide object recognition as a feature in a retinal implant system. Participants will be able to direct an object recognition application to find a desired object in the field of view of the head-mounted camera, and to direct the participant's view towards it through the presentation of a recognizable icon. A prototype system will be developed and evaluated in human subjects in phase I. A full system implementation and a second phase of the trial will be completed in phase II.

Conditions Studied

Interventions

  • DEVICE Object recognition subsystem

Study Locations (1)

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2017-07-01
Est. Completion 2022-08-31
Phase NA

Sponsor

Minnesota HealthSolutions

9 total trials

What the Registry Record Tells You About NCT04319809

The ClinicalTrials.gov registry entry for NCT04319809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (97% lower). The listed sponsor is Minnesota HealthSolutions, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 1 intervention - of which Object recognition subsystem is the first listed.

NCT04319809 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT04319809 about?

NCT04319809 is a clinical study titled "Object Finder for a Retinal Prosthesis". The proposed project seeks to provide object recognition as a feature in a retinal implant system. Participants will be able to direct an object recognition application to find a desired object in the field of view of the head-mounted camera, and to direct the participant's view towards it through t...

What is the current status of trial NCT04319809?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2017-07-01. Estimated completion is 2022-08-31.

What conditions does trial NCT04319809 study?

This clinical trial studies the following conditions: Retinitis Pigmentosa.

What interventions are being tested in trial NCT04319809?

The interventions under investigation include: Object recognition subsystem (DEVICE).

Who is sponsoring clinical trial NCT04319809?

This trial is sponsored by Minnesota HealthSolutions, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04319809 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Retinitis Pigmentosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.